Company: LGN
Filing Date: 2025-07-15
Form Type: DRS/A
Source: 0000950123-25-006399
Chunk: 223

Company: Legence Corp.
Filing Date: 2025-07-15
Form: DRS/A
Chunk 223
---
 Class B Common Stock will vote together with holders of our Class A Common Stock as a single class on all
matters on which stockholders are entitled to vote generally, except as otherwise required by applicable law or by our amended and restated certificate of incorporation.

153

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 Holders of our Class B Common Stock do not have any right to receive dividends or to receive a distribution upon a liquidation, dissolution or winding up of Legence. Any holder of Class B Common Stock that does not also hold LGN Units is required to surrender any such shares of Class B Common Stock (including fractions thereof) to Legence. Preferred Stock No shares of preferred stock will be issued or outstanding immediately after the offering contemplated by this prospectus. Our amended and restated certificate of incorporation authorizes our board of directors to establish one or more series of preferred stock (including convertible preferred stock). Unless required by law or any stock exchange, the authorized shares of preferred stock will be available for issuance without further action by the holders of our Common Stock. Our board of directors is able to determine, with respect to any series of preferred stock, the powers (including voting powers), preferences and relative, participating, optional or other special rights, and the qualifications, limitations or restrictions thereof, including, without limitation:

| • |     | the designation of the series; |

| • |     | the number of shares of the series, which our board of directors may, except where otherwise provided in the                                                                
 preferred stock designation, increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares then outstanding); |

| • |     | whether dividends, if any, will be cumulative or non-cumulative and the 
 dividend rate of the series;                                            |

| • |     | the dates at which dividends, if any, will be payable; |

| • |     | the redemption or repurchase rights and price or prices, if any, for shares of the series; |

| • |     | the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series; |

| • |     | the amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution 
 or winding-up of our affairs;                                                                                     |

| • |     | whether the shares of the series will be convertible into shares of any other class or